[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Simulations Plus Inc (SLP)

Simulations Plus Inc (SLP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 336,413
  • Shares Outstanding, K 20,205
  • Annual Sales, $ 79,180 K
  • Annual Income, $ -64,720 K
  • EBIT $ -67 M
  • EBITDA $ -59 M
  • 60-Month Beta 1.33
  • Price/Sales 4.13
  • Price/Cash Flow 11.30
  • Price/Book 2.44

Options Overview Details

View History
  • Implied Volatility 92.47% (+10.82%)
  • Historical Volatility 64.19%
  • IV Percentile 87%
  • IV Rank 50.20%
  • IV High 149.14% on 01/30/26
  • IV Low 35.35% on 01/22/26
  • Expected Move (DTE 13) 1.59 (10.01%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 32
  • Volume Avg (30-Day) 43
  • Put/Call OI Ratio 1.70
  • Today's Open Interest 1,402
  • Open Int (30-Day) 1,426
  • Expected Range 14.29 to 17.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 05/31/26
See More
  • Average Estimate $0.23
  • Number of Estimates 1
  • High Estimate $0.23
  • Low Estimate $0.23
  • Prior Year $0.45
  • Growth Rate Est. (year over year) -48.89%

Price Performance

See More
Period Period Low Period High Performance
1-Month
13.21 +20.21%
on 05/15/26
17.76 -10.61%
on 06/01/26
+0.17 (+1.08%)
since 05/05/26
3-Month
11.09 +43.19%
on 03/30/26
17.76 -10.61%
on 06/01/26
+3.46 (+27.86%)
since 03/05/26
52-Week
11.09 +43.19%
on 03/30/26
28.65 -44.57%
on 06/09/25
-11.91 (-42.86%)
since 06/05/25

Most Recent Stories

More News
SLP Shareholder Alert: Robbins LLP Reminds Simulation Plus, Inc. Stockholders that it is Investigating the Company's Officers and Directors to Determine if They Violated Securities Laws and Breached Fiduciary Duties to Shareholders

SAN DIEGO , June 2, 2026 /PRNewswire/ -- Shareholder rights law firm  Robbins LLP  is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers...

SLP : 15.88 (-4.62%)
Simulations Plus, Inc. (SLP) Securities Fraud Investigation: Johnson Fistel Investigates Investor Losses Following Revenue Outlook Revision, Impairment Charge, and Auditor Dispute

Johnson Fistel, PLLP is investigating potential claims on behalf of Simulations Plus, Inc. (NASDAQ: SLP) investors concerning whether the Company or certain of its executive officers violated federal securities...

SLP : 15.88 (-4.62%)
Robbins LLP is Investigating Allegations that the Officers and Directors of Simulations Plus, Inc. (SLP) Violated Securities Laws and Breached Fiduciary Duties to Shareholders

Shareholder rights law firm Robbins LLP is investigating Simulation Plus, Inc. (NASDAQ: SLP) to determine whether certain Simulation Plus officers and directors violated securities laws...

SLP : 15.88 (-4.62%)
Simulations Plus to Participate in the 23rd Annual Craig-Hallum Institutional Investor Conference

Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced...

SLP : 15.88 (-4.62%)
Simulations Plus and NVIDIA Collaborate to Scale GPU-Accelerated, AI-Assisted Modeling Workflows

Combines validated scientific engines with accelerated computing and AI to enable more scalable, integrated modeling workflows across the drug development lifecycle

SLP : 15.88 (-4.62%)
Simulations Plus Announces Collaboration with Lonza and U.S. FDA to Advance Predictive Frameworks for Complex Oral Drug Products

Mechanistic modeling approach and experimental integration designed to improve early risk identification, strengthen regulatory confidence, and expand AI-enabled workflows connecting data to decision-making...

SLP : 15.88 (-4.62%)
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School

More than 1,400 participants across 65+ countries underscores accelerating adoption of model-informed workflows and growing demand for applied modeling expertise

SLP : 15.88 (-4.62%)
Simulations Plus: Fiscal Q2 Earnings Snapshot

Simulations Plus: Fiscal Q2 Earnings Snapshot

SLP : 15.88 (-4.62%)
Simulations Plus Reports Second Quarter Fiscal 2026 Financial Results

Revenue grew 8% with increases in both software and services

SLP : 15.88 (-4.62%)
Simulations Plus Announces Second Quarter Fiscal Year 2026 Earnings and Conference Call Date

Conference call to be on Thursday, April 9, 2026, at 5 p.m. ET

SLP : 15.88 (-4.62%)

Business Summary

Simulations Plus, Inc., is a premier developer of groundbreaking drug discovery and development simulation software, which is licensed to and used in the conduct of drug research by major pharmaceutical and biotechnology companies worldwide. They have two other businesses, Words+, Inc. and FutureLab,...

See More

Key Turning Points

3rd Resistance Point 17.51
2nd Resistance Point 17.13
1st Resistance Point 16.50
Last Price 15.88
1st Support Level 15.49
2nd Support Level 15.11
3rd Support Level 14.48

See More

52-Week High 28.65
Fibonacci 61.8% 21.94
Fibonacci 50% 19.87
Fibonacci 38.2% 17.80
Last Price 15.88
52-Week Low 11.09

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.